Anti-inflammatory Effects of Botulinum Toxin Type A in a Complete Freund’s Adjuvant-Induced Arthritic Knee Joint of Hind Leg on Rat Model
- 12 December 2013
- journal article
- research article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 26 (1) , 32-39
Abstract
The objective of the study is to verify histopathologically the anti-inflammatory effect of botulinum toxin type A (BoNT-A) in a Complete Freund’s Adjuvant (CFA)-induced arthritic knee joint of hind leg on rat model using immunofluorescent staining of anti-ionized calcium-binding adaptor molecule 1 (Iba-1) and interleukin-1β (IL-1β) antibody. Twenty-eight experimental rats were injected with 0.1 ml of CFA solution in the knee joint of the hind leg bilaterally. Three weeks after CFA injection, the BoNT-A group (N = 14) was injected with 20 IU (0.1 ml) of BoNT-A bilaterally while the saline group (N = 14) was injected with 0.1 ml of saline in the knee joint of the hind leg bilaterally. One and two weeks after BoNT-A or saline injection, joint inflammation was investigated in seven rats from each group using histopathological and immune-fluorescent staining of Iba-1 and IL-1β antibody. The number of Iba-1 and IL-1β immune-reactive (IR) cells was counted in the BoNT-A and saline groups for comparison. There was a significant reduction in joint inflammation and destruction in the BoNT-A group at 1 and 2 weeks after BoNT-A injection compared with the saline group. The binding of Iba-1 and IL-1β antibody was significantly lower in the BoNT-A group than the saline group at 1 and 2 weeks after BoNT-A injection. The number of Iba-1 and IL-1β-IR cells at 1 and 2 weeks after the injection of BoNT-A were significantly different from the corresponding number of Iba-1 and IL-1β-IR cells in the saline group. To conclude, BoNT-A had an anti-inflammatory effect in a CFA-induced arthritic rat model, indicating that BoNT-A could potentially be used to treat inflammatory joint pain.Keywords
This publication has 26 references indexed in Scilit:
- Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synoviumOsteoarthritis and Cartilage, 2012
- Botulinum Neurotoxin for Pain Management: Insights from Animal ModelsToxins, 2010
- Analgesic effects of intra-articular botulinum toxin Type B in a murine model of chronic degenerative knee arthritis painJournal of Pain Research, 2010
- Efficacy of Intra‐Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot StudyPM&R, 2010
- Pain Behavior Measures to Quantitate Joint Pain and Response to Neurotoxin Treatment in Murine Models of ArthritisPain Medicine, 2009
- Lack of anti‐inflammatory effect of botulinum toxin type A in experimental models of inflammationFundamental & Clinical Pharmacology, 2008
- Long-Distance Retrograde Effects of Botulinum Neurotoxin AThe Journal of Neuroscience, 2008
- Effects of Intra-articular Botulinum Toxin Type A in an Equine Model of Acute SynovitisAmerican Journal of Physical Medicine & Rehabilitation, 2007
- Botulinum toxin, Quo Vadis?Medical Hypotheses, 2007
- Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effectsExpert Opinion on Investigational Drugs, 2001